Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study
Clinical trial NCT00873041 · COMPLETED
Trial details
- NCT number
- NCT00873041
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2011-06-01
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.